Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-28
2000-11-28
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514345, 546144, 546290, C07D21700, A61K 3147, A61K 3144
Patent
active
061536229
ABSTRACT:
Compounds of this formula ##STR1## are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
REFERENCES:
patent: 3234090 (1966-02-01), Huchner et al.
patent: 3274213 (1966-09-01), Lednicer
patent: 3277106 (1966-10-01), Bencze et al.
patent: 3293263 (1966-12-01), Lednicer
patent: 3320271 (1967-05-01), Lednicer
patent: 3396169 (1968-08-01), Duncan et al.
patent: 3483293 (1969-12-01), Duncan et al.
patent: 3567737 (1971-03-01), Lednicer et al.
patent: 3862232 (1975-01-01), Lednicer
patent: 4133814 (1979-01-01), Jones et al.
patent: 4358593 (1982-11-01), Jones et al.
patent: 4380635 (1983-04-01), Peters
patent: 4418068 (1983-11-01), Jones
patent: 5470854 (1995-11-01), Von Angerer et al.
patent: 5472962 (1995-12-01), Koizumi et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5484798 (1996-01-01), Bryant et al.
patent: 5510357 (1996-04-01), Palkowitz
patent: 5532382 (1996-07-01), Carlson et al.
patent: 5552412 (1996-09-01), Cameron et al.
patent: 5567828 (1996-10-01), Dodge
Lednicer, Daniel, et al., J. Med. Chem. 10 78 (1967) "Mammalian Antifertility Agents. IV. Basic, 3,4-Dihydronaphthalenes and 1,2,3,4-Tetrahydro-1-naphthols".
Bencze, W.L., et al., J. Med. Chem. 10 139 (1967) "Synthetic Estrogens, Implantation Inhibitors, and Hypocholesterolemic Agents. I. Tetrahydronaphthalene Series".
Lednicer, Daniel, et al., J. Med. Chem. 12 881 (1969) "Mammalian Antifertility Agents. VII. A Novel Sequence for the Preparation of 1,2-Disubstituted 3,4-Dihydronaphthalenes".
Jones, Robert C., Acta Endocrinologica (Copenh) 1987, 114:379-382 The Effect of a Luteinizing Hormone-Releasing Hormone Antagonist on Experimental Endometriosis in the Rat.
OsteoporosisConference, CRIP No. 1812/13 Apr. 16th/20th 1993. p. 29-30.
Jones, Charles D., et al., J. Med. Chem. (1984) 27, 1057-1066 "Antiestrogens. 2. Structure-Activity Studies in a Series of 3-Aroyl-2-arylbenzo[b]thiophene Derivatives Leading to [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)etho xy]-phenyl]methanone Hydrochloride (LY156758), a Remarkably Effective Estrogen Antagonist with Only Minimal Intrinsic Estrogenicity".
Chemical Abstract, vol. 64, pp. 15811-15814, 1966.
Cameron Kimberly O.
Dasilva-Jardine Paul A.
Ke Hua Zhu
Rosati Robert L.
Benson Gregg C.
Brokke Mervin E.
Davis Zinna Northington
Pfizer Inc.
Richardson Peter C.
LandOfFree
Estrogen agonists/antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrogen agonists/antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrogen agonists/antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726104